Search results
Paxlovid Drug Interactions
Verywell Health via Yahoo News· 4 months agoWhat to avoid with this at-home COVID-19 treatment Medically reviewed by Femi Aremu, PharmD Paxlovid is a combination antiviral medication that contains...
3 Drug Stocks Most Wall Street Analysts Are Bullish About
Zacks via Yahoo Finance· 1 year agoHere we present three drug and biotech stocks, UTHR, ITCI and IMCR, which most analysts on Wall...
United Therapeutics (UTHR) Q4 Earnings & Sales Miss Estimates
Zacks via Yahoo Finance· 1 year agoUnited Therapeutics‘ UTHR fourth-quarter 2022 adjusted earnings of $2.67 per share missed the Zacks...
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
Zacks via Yahoo Finance· 1 month agoUnited Therapeutics‘ UTHR first-quarter 2024 earnings of $6.17 per share beat the Zacks Consensus...
Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair
Zacks via Yahoo Finance· 2 months agoMerck MRK announced that the FDA has granted approval to its novel activin signaling inhibitor,...
United Therapeutics (UTHR) Q2 Earnings Miss Estimates, Revenues Up
Zacks via Yahoo Finance· 2 years agoUnited Therapeutics' (UTHR) second-quarter earnings missed estimates, while sales beat the same....
How Does Cialis (Tadalafil) Work?
Verywell Health via Yahoo News· 8 months agoCialis (tadalafil) is an orally administered prescription medication used for erectile dysfunction (ED) and pulmonary arterial hypertension (PAH) to...
Cialis vs. Viagra: Which Is More Effective?
Verywell Health via Yahoo News· 1 year agoThe two ED medications are similarly effective but have key differencesMedically reviewed by Jamin Brahmbhatt, MD Cialis and Viagra are the most common...
FDA Accepts Merck's (MRK) Filing for Sotatercept in PAH Disease
Zacks via Yahoo Finance· 8 months agoThe FDA grants priority review to Merck's (MRK) FDA filing for sotatercept to treat adults with...
Merck (MRK) Posts Positive Results From PAH Drug Study
Zacks via Yahoo Finance· 2 years agoMerck's (MRK) sotatercept meets primary and secondary endpoints in a phase III study in pulmonary...
